← Eichor
Condition: Viral Hepatitis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Viral Hepatitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.
NA · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT04231565A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear S
Phase 3 · 1 location(s) · Huahui Health · NCT07499544Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese
Phase N/A · 1 location(s) · Ruijin Hospital · NCT05870969Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures
Phase N/A · 1 location(s) · University Hospital, Limoges · NCT05361603Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis
Phase N/A · 6 location(s) · Hospices Civils de Lyon · NCT03825458Hepatitis Delta Virus Infection: Cross-sectional Study in Patients With Chronic Hepatitis B Virus Infection
Phase N/A · 3 location(s) · Tam Anh Research Institute · NCT06638320Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients
Phase 1 · 1 location(s) · Changhai Hospital · NCT06885710A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs
Phase 2 · 1 location(s) · Ausper Biopharma Co., Ltd. · NCT07069569Comparison of TAF and TDF in Preventing Mother-to-Child Transmission of HBV in Pregnancies With High Viral Loads
NA · 10 location(s) · Guangzhou 8th People's Hospital · NCT06947356VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B
Phase 2 · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT06092333Blood Collection Biorepository for Liver Disease Research
Phase N/A · 1 location(s) · State University of New York at Buffalo · NCT03025074Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)
Phase N/A · 2 location(s) · MagIA Diagnostics · NCT07170748Research on Clinical Recovery and Maintenance Strategies for CHB
NA · 1 location(s) · Beijing Municipal Administration of Hospitals · NCT06803368Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B
Phase N/A · 1 location(s) · Huashan Hospital · NCT04896255TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B
Phase 1 · 1 location(s) · University of Maryland, Baltimore · NCT04843852A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.
Phase 3 · 8 location(s) · GC Biopharma Corp · NCT05686759Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody (The SAMBA Study)
Phase 1 · 1 location(s) · Aarhus University Hospital · NCT06668727Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance
Phase N/A · 1 location(s) · Beijing Friendship Hospital · NCT06779864Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B
Phase 4 · 1 location(s) · Taichung Veterans General Hospital · NCT03933384The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset
Phase N/A · 12 location(s) · Kirby Institute · NCT05713136A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test
NA · 3 location(s) · bioLytical Laboratories · NCT07563309Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide
Phase 2/Phase 3 · 35 location(s) · Mirum Pharmaceuticals, Inc. · NCT07454837Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors
Phase 4 · 1 location(s) · University Health Network, Toronto · NCT07189377ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings
NA · 32 location(s) · Kirby Institute · NCT03685045Impact of Hepatitis B Virus on Inflammatory Bowel Disease
Phase N/A · 1 location(s) · Tanta University · NCT06881238Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus
Phase 1/Phase 2 · 19 location(s) · Gilead Sciences · NCT07096193Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
Phase 4 · 1 location(s) · Mercy Medical Center · NCT04588077Screening of Patients With Hepatic Fibrosis or Cirrhosis B and C
NA · 2 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06755632Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
NA · 1 location(s) · University of California, San Francisco · NCT06179498
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.